Immune cell activation pathways

Immune cell activation pathways" is not a canonical name for any single molecule or therapeutic target. Instead, it refers broadly to the complex network of intracellular and intercellular signaling cascades that govern how immune cells detect pathogens and become activated. These include both innate immunity mechanisms—such as pattern recognition receptors like Toll-like receptors—and adaptive immunity processes involving T-cell receptor and B-cell receptor signaling. Key molecular families involved include cytokine receptors, kinases (e.g., JAK/STAT), transcription factors (e.g., NF-kB), complement system proteins, and co-stimulatory/inhibitory molecules on lymphocytes. These interconnected networks regulate essential functions such as pathogen recognition, inflammation initiation/resolution, antibody production by B cells following antigen binding to their receptors, cytotoxic responses by T cells against infected or malignant cells, and recruitment/activation of other leukocytes via cytokines[1][6]. Dysregulation can lead to increased infection risk or inappropriate inflammation/autoimmunity. Because "immune cell activation pathways" encompasses many distinct molecules rather than one defined entity—and is not itself a druggable target—it should not be considered a canonical therapeutic target but rather an umbrella term describing multiple potential intervention points in immunology research and therapy development[1][6].

Other names

Immune activation pathwaysImmune cell signaling pathwaysImmune response signaling cascades

Mechanisms of action depend on the specific molecular targets within these broad pathways. For example, checkpoint inhibitors block inhibitory signals in T-cell receptor signaling.